Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015...
Transcript of Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015...
![Page 1: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/1.jpg)
Canadian Retina Society 2015
Canadian Practices and Trends Survey (CAN-PAT)
Netan Choudhry MD FRCS(C) Matthew Tenant MD FRCS(C) James Whelan MD FRCS(C)
![Page 2: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/2.jpg)
CRS 2015: CAN-PAT
In what province or territory is your primary practice located?
![Page 3: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/3.jpg)
CRS 2015: CAN-PAT
What is your primary practice setting?
![Page 4: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/4.jpg)
CRS 2015: CAN-PAT
How long have you been in practice after fellowship?
![Page 5: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/5.jpg)
CRS 2015: CAN-PAT
What is your first-line agent for wet age-related macular degeneration (ARMD)?
![Page 6: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/6.jpg)
CRS 2015: CAN-PAT
Do you use fluorescein angiography (FA) in the initial evaluation of suspected wet ARMD?
![Page 7: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/7.jpg)
CRS 2015: CAN-PAT
When performing automatic intravitreal injections of anti-VEGF medication, when do you reassess the patient
with dilated slit lamp examination?
![Page 8: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/8.jpg)
CRS 2015: CAN-PAT
What follow-up testing do you perform for ARMD patients after anti-VEGF therapy?
![Page 9: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/9.jpg)
CRS 2015: CAN-PAT
Which anti-VEGF agent do you find most effective in decreasing fluid in wet ARMD?
![Page 10: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/10.jpg)
CRS 2015: CAN-PAT
What is your anti-VEGF therapy management choice for patients with bilateral wet ARMD?
![Page 11: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/11.jpg)
CRS 2015: CAN-PAT
What defines an inadequate response to an anti-VEGF treatment in wet ARMD? Check all that apply
![Page 12: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/12.jpg)
CRS 2015: CAN-PAT
How do you manage persistent choroidal neovascularization (CNV) ARMD activity after 8 monthly anti-VEGF injections,
VA = 20/50?
![Page 13: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/13.jpg)
CRS 2015: CAN-PAT
Which anti-VEGF agent do you believe treats the broadest range of wet ARMD patients, including naïve patients, those previously treated with an anti-VEGF agent, and those with pigment epithelial detachments (PED)?
![Page 14: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/14.jpg)
CRS 2015: CAN-PAT
What is your preferred ocular vitamin for the treatment of dry ARMD?
![Page 15: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/15.jpg)
CRS 2015: CAN-PAT
How would you describe your use of commerical genetic testing for known mutations associated with ARMD risk?
![Page 16: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/16.jpg)
CRS 2015: CAN-PAT
What is your approach to chronic (6 months) central serous chorioretinopathy (CSCR), VA = 20/40, diffuse
leak involving the fovea?
![Page 17: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/17.jpg)
CRS 2015: CAN-PAT
If you treat CSCR, what ancillary testing do you utilize? Please check all that apply.
![Page 18: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/18.jpg)
CRS 2015: CAN-PAT
How would you treat a high myope with a new choroidal neovascular membrane (CNVM)?
![Page 19: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/19.jpg)
CRS 2015: CAN-PAT
What type of anesthesia do you use for intravitreal injections?
![Page 20: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/20.jpg)
CRS 2015: CAN-PAT
How would you treat a recent central retinal vein occlusion (CRVO) with vision-affecting macular edema?
![Page 21: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/21.jpg)
CRS 2015: CAN-PAT
What is your initial treatment choice for a 64-year-old patient with branch retinal vein occlusion (BRVO),
macular edema, VA = 20/60?
![Page 22: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/22.jpg)
CRS 2015: CAN-PAT
When do you recommend macular grid laser for BRVO?
![Page 23: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/23.jpg)
CRS 2015: CAN-PAT
How would you treat macular edema from a BRVO that is unresponsive to Avastin?
![Page 24: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/24.jpg)
CRS 2015: CAN-PAT
How would you treat a BRVO with persistent edema after 6 monthly anti-VEGF injections and
peripheral ischemia?
![Page 25: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/25.jpg)
CRS 2015: CAN-PAT
Who performs retinopathy of prematurity (ROP) screening at your local neonatal intensive care unit (NICU)?
![Page 26: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/26.jpg)
CRS 2015: CAN-PAT
Would you use Avastin in a child?
![Page 27: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/27.jpg)
CRS 2015: CAN-PAT
What is your first-line therapy for a new phakic diabetic patient with VA = 20/50 and centre-involving
diabetic macular edema (DME)?
![Page 28: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/28.jpg)
CRS 2015: CAN-PAT
How would you treat DME refractory to laser and Lucentis (6 prior injections)?
![Page 29: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/29.jpg)
CRS 2015: CAN-PAT
How would you manage a clinically significant DME patient with VA = 20/25 and centre-involving fluid on OCT who is phakic?
![Page 30: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/30.jpg)
CRS 2015: CAN-PAT
Regarding the treatment of DME with anti-VEGF agents, how many injections of anti-VEGF do you usually perform in the
first year of treatment?
![Page 31: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/31.jpg)
CRS 2015: CAN-PAT
What is your protocol for treating DME with macular laser?
![Page 32: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/32.jpg)
CRS 2015: CAN-PAT
How would you treat a diabetic with microaneurysms, but no edema before cataract surgery?
![Page 33: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/33.jpg)
CRS 2015: CAN-PAT
When do you usually begin PRP laser in compliant diabetic patients?
![Page 34: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/34.jpg)
CRS 2015: CAN-PAT
How would you initially treat a tractional retinal detachment (TRD) along the arcades in a previously
untreated diabetic?
![Page 35: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/35.jpg)
CRS 2015: CAN-PAT
Which group is most important to educate about DME to drive timely referrals to retina specialists?
![Page 36: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/36.jpg)
CRS 2015: CAN-PAT
How do you manage a patient with a small stage 2 macular hole (<200 microns) with concurrent traction?
![Page 37: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/37.jpg)
CRS 2015: CAN-PAT
How do you manage a patient with a medium stage 2 macular hole (<400 microns) with concurrent traction?
![Page 38: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/38.jpg)
CRS 2015: CAN-PAT
How do you manage a patient with a stage 3 full-thickness macular hole (>400 microns) with concurrent traction?
![Page 39: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/39.jpg)
CRS 2015: CAN-PAT
Do you (or your technician) measure the size of a macular hole/vitreomacular traction on OCT prior to deciding on the
type of treatment?
![Page 40: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/40.jpg)
CRS 2015: CAN-PAT
How is a patient with symptomatic focal VMT and VA = 20/60 best managed?
![Page 41: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/41.jpg)
CRS 2015: CAN-PAT
Which anti-VEGF agent allows the longest treatment interval for ARMD patients in your clinical experience?
![Page 42: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/42.jpg)
CRS 2015: CAN-PAT
Which intravitreal agent allows the longest treatment interval for CRVO patients in your clinical experience?
![Page 43: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/43.jpg)
CRS 2015: CAN-PAT
In your experience, what percentage of serous PED patients who failed Avastin and Lucentis responded to Eylea?
![Page 44: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/44.jpg)
CRS 2015: CAN-PAT
When evaluating systemic safety of anti-VEGF agents, what data are most important to you?
![Page 45: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/45.jpg)
CRS 2015: CAN-PAT
Have you switched your ARMD patients to the latest AREDS 2 formulation?
![Page 46: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/46.jpg)
CRS 2015: CAN-PAT
What diagnostic tool do you think is most effective in the screening of hydroxychloroquine (Plaquenil) toxicity?
![Page 47: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/47.jpg)
CRS 2015: CAN-PAT
Should vision rehabilitation therapy for patients with vision loss be funded by the government?
![Page 48: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/48.jpg)
CRS 2015: CAN-PAT
When speaking with patient with severe vision loss, do you discuss the possibility of the patient developing
Charles Bonnet hallucinations?
![Page 49: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/49.jpg)
CRS 2015: CAN-PAT
Are you a Surgical Retina Specialist?
![Page 50: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/50.jpg)
CRS 2015: CAN-PAT
What type of local anesthetic do you utilize for an uncomplicated vitrectomy?
![Page 51: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/51.jpg)
CRS 2015: CAN-PAT
Which gauge vitrectomy system do you prefer?
![Page 52: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/52.jpg)
CRS 2015: CAN-PAT
Which vitrectomy platform feature is most important to you?
![Page 53: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/53.jpg)
CRS 2015: CAN-PAT
What devices are most important to you during vitrectomy surgery? Please check all that apply.
![Page 54: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/54.jpg)
CRS 2015: CAN-PAT
What percentage of the time do you use perfluorcarbon liquid in vitrectomy for routine primary rhegmatogenous retinal
detachment (RRD) without proliferative vitreoretinopathy (PVR)?
![Page 55: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/55.jpg)
CRS 2015: CAN-PAT
In what percentage of cases do you peel ILM during a routine vitrectomy for macular hole?
![Page 56: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/56.jpg)
CRS 2015: CAN-PAT
How do you manage persistent vitreous hemorrhage 1 week after vitrectomy for PDR?
![Page 57: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/57.jpg)
CRS 2015: CAN-PAT
How often do you perform pneumatic retinopexy?
![Page 58: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/58.jpg)
CRS 2015: CAN-PAT
What is your usual recommendation for a pseudophakic superior RD, macula-on -3.00D myope, single tear?
![Page 59: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/59.jpg)
CRS 2015: CAN-PAT
What is your post-operative regimen following vitrectomy for retinal detachment repair?
![Page 60: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/60.jpg)
CRS 2015: CAN-PAT
How many vitrectomies for floaters have you performed in the past year?
![Page 61: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/61.jpg)
CRS 2015: CAN-PAT
Which type of vitreoretinal pathology do you consider the most complex/difficult to repair?
![Page 62: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/62.jpg)
CRS 2015: CAN-PAT
What is your preferred method of initiating peeling of an epiretinal membrane (ERM)?
![Page 63: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/63.jpg)
CRS 2015: CAN-PAT
What percentage of the time do you perform vitrectomies or scleral buckles under general anesthesia?
![Page 64: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/64.jpg)
CRS 2015: CAN-PAT
When surgically managing proliferative vitreoretinopathy for recurrent retinal detachment I do the following:
![Page 65: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/65.jpg)
CRS 2015: CAN-PAT
When surgically managing proliferative vitreoretinopathy for recurrent retinal detachment I do the following:
![Page 66: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/66.jpg)
CRS 2015: CAN-PAT
When surgically managing proliferative vitreoretinopathy for recurrent retinal detachment I do the following:
![Page 67: Canadian Practices and Trends Survey (CAN-PAT) · 2020-04-27 · Canadian Retina Society 2015 Canadian Practices and Trends Survey (CAN-PAT) Netan Choudhry MD FRCS(C)! Matthew Tenant](https://reader034.fdocuments.us/reader034/viewer/2022042310/5ed86c57b7394006ce602b3e/html5/thumbnails/67.jpg)
Canadian Retina Society 2015
Thank you
Netan Choudhry MD FRCS(C) Matthew Tenant MD FRCS(C) James Whelan MD FRCS(C)
CAN-PAT Commitee